ENTOS Trademark

Trademark Overview

On Wednesday, September 14, 2022, a trademark application was filed for ENTOS with the United States Patent and Trademark Office. The USPTO has given the ENTOS trademark a serial number of 97980623. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Sunday, September 28, 2025. This trademark is owned by Entos Pharmaceuticals Inc.. The ENTOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations and substances, namely, human vaccines; chronic diseases, namely, chronic neurological and nervous system diseases and other mental illnesses, chronic eye diseases, chronic muscle diseases, and cancers in the nature of hematological cancers and solid organ cancers; vaccines that are viral, bacterial, fungal for human use; therapeutic and preventative cancer vaccines for human use; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseases and disorders, namely, inflammatory muscle diseases and disorders, diabetes, obesity, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, muscular dystrophy, genetic diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, respiratory diseases and disorders, rare and orphan diseases, and rare genetic diseases and disorders, namel...
entos

General Information

Serial Number97980623
Word MarkENTOS
Filing DateWednesday, September 14, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSunday, September 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements

Goods and ServicesPharmaceutical and medicinal preparations and substances, namely, human vaccines; chronic diseases, namely, chronic neurological and nervous system diseases and other mental illnesses, chronic eye diseases, chronic muscle diseases, and cancers in the nature of hematological cancers and solid organ cancers; vaccines that are viral, bacterial, fungal for human use; therapeutic and preventative cancer vaccines for human use; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseases and disorders, namely, inflammatory muscle diseases and disorders, diabetes, obesity, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, muscular dystrophy, genetic diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, respiratory diseases and disorders, rare and orphan diseases, and rare genetic diseases and disorders, namely, rare respiratory, pulmonary and lung diseases, rare liver diseases, rare eye diseases, rare muscle diseases
Translation of Words in MarkThe English translation of the word "Entos" in the mark is "within".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2022
Primary Code005
First Use Anywhere DateThursday, January 31, 2019
First Use In Commerce DateThursday, January 31, 2019

Trademark Owner History

Party NameEntos Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEdmonton, Alberta T5J4P6
CA
Party NameEntos Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdmonton, Alberta T5J4P6
CA

Trademark Events

Event DateEvent Description
Saturday, September 17, 2022NEW APPLICATION ENTERED
Thursday, September 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 27, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, November 16, 2023DIVISIONAL REQUEST RECEIVED
Thursday, November 16, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, November 16, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, November 16, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 26, 2023ASSIGNED TO EXAMINER
Tuesday, June 27, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 27, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 27, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, March 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 8, 2024DIVISIONAL PROCESSING COMPLETE
Monday, March 11, 2024EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 12, 2024EXAMINER'S AMENDMENT ENTERED
Friday, March 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 28, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Monday, March 11, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, March 11, 2024ASSIGNED TO LIE
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 30, 2024SOU EXTENSION 1 FILED
Monday, December 30, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 7, 2025SOU EXTENSION 1 GRANTED
Monday, June 30, 2025USE AMENDMENT FILED
Monday, June 30, 2025TEAS REQUEST TO DIVIDE RECEIVED
Monday, June 30, 2025TEAS STATEMENT OF USE RECEIVED
Friday, September 5, 2025DIVISIONAL PROCESSING COMPLETE
Sunday, September 28, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, September 28, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 5, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, October 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2025DIVISIONAL REQUEST RECEIVED

Related Keywords

entos diseases disorders namely chronic cancers pharmaceutical vaccines genetic human preparations